Skip to main content

Rs 350 to Rs 1,150: This stock has turned into a multibagger in over a month

The small cap share which stood at Rs 350 on September 21 has risen to Rs 1150 till date, delivering 228% returns to investors

 

Route Mobile share has become a multibagger during last 1.5 months. The stock of cloud communications service provider has tripled since September 21, its market debut date. Share of Route Mobile which stood at Rs 350 on September 21 has risen to Rs 1150 till date, delivering 228% returns to investors.



 

The small cap stock has gained 40.02% in last six days. It opened with a gain of 5% at Rs 1,150, hitting a fresh all-time high today.

Route Mobile share is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. In one month, the share has gained 42.59% and risen 34.69% during a week.

 

The stock has gained 26% in the last four sessions after the firm reported its Q2 profit on October 29. The share rose from Rs 912.75 on October 29 to Rs 1150 today, gaining Rs 238 during the period.

 

Route Mobile reported a 152% rise in net profit for the quarter ended September. Route Mobile reported net profit of Rs 32.7 crore in Q2 against Rs 13 crore profit in corresponding quarter of previous fiscal.

 

Revenue rose 76% to Rs 354.5 crore in Q2 against Rs 201.4 crore revenue in corrspsonding period of previous fiscal.

The firm also reported 128% rise in profit after tax at Rs 59.7 crore in first half of  the current fiscal against Rs 26.2 crore profit during the corresponding period of previous fiscal.

 

Apart from  strong Q2 earnings, share of Route Mobile was lapped up by US-based investment bank Goldman Sachs which also increased its demand in the stock market.

 

Goldman Sachs which was already an anchor investor in the IPO of Route Mobile bought an additional 24.09 lakh equity shares or 4.23 percent stake in the firm via open market transactions on September 22.

 

Kuwait Investment Authority, also an anchor investor in the IPO, bought another 5,78,504 shares in Route Mobile (representing 1.01 percent of the total paid-up equity) at Rs 697.25 per share, a 99.2 percent premium over its issue price.

 

This lifted the stock by 7% intra day  to Rs 695 on BSE.

Earlier on September 21, the share made a stellar debut on BSE and NSE delivering over 100% gains to its investors.

 

Stock of Route Mobile listed at a premium of 102.28% above its IPO issue price of Rs 350 on BSE.  Route Mobile share opened at Rs 708, gaining Rs 358 compared to its issue price.  

 

The share further rose to an intra day high of Rs 735, a gain of Rs 385 or 110%  above its issue price. On NSE, the share opened at Rs 717, gaining 104.85% to its issue price of Rs 350. Route Mobile stock rose 110% above its issue price to Rs 735 on an intra day basis.

 Source - Businesstoday

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more